Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia flag Australia · Delayed Price · Currency is AUD
10.16
+0.16 (1.60%)
Mar 10, 2026, 1:59 PM AEST

Clinuvel Pharmaceuticals Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Cash & Equivalents
36.1428.0235.231.89121.5182.69
Upgrade
Short-Term Investments
196.86196.09148.67124.92--
Upgrade
Cash & Short-Term Investments
233224.11183.87156.81121.5182.69
Upgrade
Cash Growth
17.54%21.88%17.25%29.05%46.94%23.89%
Upgrade
Accounts Receivable
16.5824.1725.0120.6415.915.81
Upgrade
Other Receivables
-3.31.231.570.30.28
Upgrade
Receivables
16.5827.4626.2422.2116.216.09
Upgrade
Inventory
8.418.8210.639.521.833.19
Upgrade
Prepaid Expenses
----1.040.88
Upgrade
Other Current Assets
3.382.581.331.07--
Upgrade
Total Current Assets
261.38262.97222.06189.62140.58102.85
Upgrade
Property, Plant & Equipment
6.487.137.722.852.72.6
Upgrade
Long-Term Investments
0.220.210.13---
Upgrade
Goodwill
----0.190.19
Upgrade
Other Intangible Assets
0.190.190.190.19--
Upgrade
Long-Term Deferred Tax Assets
1.421.261.021.060.482.93
Upgrade
Total Assets
269.7271.75231.12193.71143.95108.57
Upgrade
Accounts Payable
10.682.552.352.790.264.66
Upgrade
Accrued Expenses
2.512.291.881.452.863.7
Upgrade
Current Portion of Leases
0.310.430.370.30.320.26
Upgrade
Current Income Taxes Payable
4.3614.5515.8516.097.280.1
Upgrade
Other Current Liabilities
-7.394.764.863.02-
Upgrade
Total Current Liabilities
17.8527.2125.2125.4913.738.71
Upgrade
Long-Term Leases
0.020.10.510.70.941.05
Upgrade
Pension & Post-Retirement Benefits
-0.130.080.060.030.01
Upgrade
Long-Term Deferred Tax Liabilities
2.623.422.232.763.62-
Upgrade
Other Long-Term Liabilities
0.190.090.080.070.070.06
Upgrade
Total Liabilities
20.6830.9428.1129.0818.399.83
Upgrade
Common Stock
170.33169.28168.8151.85151.85151.85
Upgrade
Retained Earnings
71.5763.6329.96-9.77-38.4-58.13
Upgrade
Comprehensive Income & Other
7.127.94.2522.5612.115.02
Upgrade
Total Common Equity
249.02240.81203.01164.63125.5698.74
Upgrade
Shareholders' Equity
249.02240.81203.01164.63125.5698.74
Upgrade
Total Liabilities & Equity
269.7271.75231.12193.71143.95108.57
Upgrade
Total Debt
0.320.530.8811.261.3
Upgrade
Net Cash (Debt)
232.68223.58182.99155.81120.2581.39
Upgrade
Net Cash Growth
17.81%22.18%17.44%29.57%47.75%24.39%
Upgrade
Net Cash Per Share
4.604.443.593.012.321.59
Upgrade
Filing Date Shares Outstanding
50.1650.1250.0849.4149.4149.41
Upgrade
Total Common Shares Outstanding
50.1650.1250.0849.4149.4149.41
Upgrade
Working Capital
243.53235.76196.85164.12126.8594.14
Upgrade
Book Value Per Share
4.964.804.053.332.542.00
Upgrade
Tangible Book Value
248.83240.62202.83164.45125.3798.55
Upgrade
Tangible Book Value Per Share
4.964.804.053.332.541.99
Upgrade
Land
-5.024.97---
Upgrade
Machinery
-2.191.941.531.330.82
Upgrade
Leasehold Improvements
-1.991.991.891.251.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.